Integral Health Asset Management, LLC Reata Pharmaceuticals Inc Transaction History

Integral Health Asset Management, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$79.22 - $105.37 $3.88 Million - $5.16 Million	49,000 Added 69.01%	120,000 $12.2 Million
Q1 2023 May 09, 2023	SELL	$30.85 - $93.17 $431,900 - $1.3 Million	-14,000 Reduced 16.47%	71,000 $6.46 Million
Q4 2022 Feb 13, 2023	BUY	$22.15 - $42.11 $1.88 Million - $3.58 Million	85,000 New	85,000 $3.23 Million
Q2 2022 Aug 03, 2022	BUY	$20.71 - $36.5 $1.44 Million - $2.53 Million	69,369 Added 198.2%	104,369 $3.17 Million
Q1 2022 May 12, 2022	SELL	$24.12 - $39.6 $1.64 Million - $2.69 Million	-68,000 Reduced 66.02%	35,000 $1.15 Million
Q4 2021 Feb 02, 2022	BUY	$25.61 - $110.96 $1.74 Million - $7.55 Million	68,000 Added 194.29%	103,000 $2.72 Million
Q3 2021 Nov 12, 2021	SELL	$100.0 - $143.02 $700,000 - $1 Million	-7,000 Reduced 16.67%	35,000 $3.52 Million
Q2 2021 Aug 30, 2021	SELL	$78.27 - $151.29 $3.29 Million - $6.35 Million	-42,000 Reduced 50.0%	42,000 $5.94 Million
Q2 2021 Aug 13, 2021	BUY	$78.27 - $151.29 $3.13 Million - $6.05 Million	40,000 Added 90.91%	84,000 $11.9 Million
Q1 2021 May 10, 2021	SELL	$94.25 - $132.81 $565,500 - $796,860	-6,000 Reduced 12.0%	44,000 $4.39 Million
Q4 2020 Feb 16, 2021	BUY	$102.03 - $184.62 $1.02 Million - $1.85 Million	10,000 Added 25.0%	50,000 $6.18 Million
Q3 2020 Nov 16, 2020	BUY	$93.53 - $163.34 $3.74 Million - $6.53 Million	40,000 New	40,000 $3.9 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Integral Health Asset Management, LLC with notifications on news.